European Patent Office

T 2086/21 of 14.05.2024

European Case Law Identifier
ECLI:EP:BA:2024:T208621.20240514
Date of decision
14 May 2024
Case number
T 2086/21
Petition for review of
-
Application number
13800681.2
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
Abstract on EPC2000 Art 056
Application title
CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
Applicant name
Aragon Pharmaceuticals, Inc.
Sloan-Kettering Institute for Cancer Research
Opponent name
Sagittarius Intellectual Property LLP
Generics (U.K.) Limited
Luigi, Rumi
Board
3.3.02
Headnote
-
Relevant legal provisions
European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(2)
Keywords
Inventive step
Catchword
Inventive step of crystalline form: unexpected beneficial combination of properties - yes (points 3.5.5 and 3.6 of the reasons)
Citing cases
-

Order

For these reasons it is decided that:

The appeals are dismissed.